Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Detail - Fair Value Schedule (Details)

v3.22.2.2
Balance Sheet Detail - Fair Value Schedule (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Cash equivalents:    
Total cash equivalents $ 485,979 $ 1,609,919
Total short-term investments 750,697 0
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Total liabilities 15,001 118,058
Public warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 5,742 37,999
Private placement warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 4,183 27,679
Earnout shares liability    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 5,076 52,380
Level 1    
Cash equivalents:    
Total cash equivalents 356,550 1,609,919
Total short-term investments 0  
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Total liabilities 5,742 37,999
Level 1 | Public warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 5,742 37,999
Level 1 | Private placement warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 0 0
Level 1 | Earnout shares liability    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 0 0
Level 2    
Cash equivalents:    
Total cash equivalents 129,429 0
Total short-term investments 750,697  
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Total liabilities 4,183 27,679
Level 2 | Public warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 0 0
Level 2 | Private placement warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 4,183 27,679
Level 2 | Earnout shares liability    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 0 0
Level 3    
Cash equivalents:    
Total cash equivalents 0 0
Total short-term investments 0  
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Total liabilities 5,076 52,380
Level 3 | Public warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 0 0
Level 3 | Private placement warrants    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 0 0
Level 3 | Earnout shares liability    
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]    
Liabilities 5,076 52,380
U.S. Treasury securities    
Cash equivalents:    
Total short-term investments 750,697  
U.S. Treasury securities | Level 1    
Cash equivalents:    
Total short-term investments 0  
U.S. Treasury securities | Level 2    
Cash equivalents:    
Total short-term investments 750,697  
U.S. Treasury securities | Level 3    
Cash equivalents:    
Total short-term investments 0  
Money market funds    
Cash equivalents:    
Total cash equivalents 356,550 1,609,919
Money market funds | Level 1    
Cash equivalents:    
Total cash equivalents 356,550 1,609,919
Money market funds | Level 2    
Cash equivalents:    
Total cash equivalents 0 0
Money market funds | Level 3    
Cash equivalents:    
Total cash equivalents 0 $ 0
U.S. Treasury securities    
Cash equivalents:    
Total cash equivalents 129,429  
U.S. Treasury securities | Level 1    
Cash equivalents:    
Total cash equivalents 0  
U.S. Treasury securities | Level 2    
Cash equivalents:    
Total cash equivalents 129,429  
U.S. Treasury securities | Level 3    
Cash equivalents:    
Total cash equivalents $ 0